ScribeMedia.Org
- ScribeMedia.Org has written 126 posts for HealthDot @ ScribeMedia.Org
- Email the author
Nanodrug Delivery
Audio Slideshow Presentation: A specific case study on the use of the nanotechnology as it transforms the pulmonary drug delivery market provides key insight on the use of these innovative technologies in drugs and devices. Also, receive pertinent updates on how the FDA views nanotechnology products and current FDA research in the nanotechnology area.
Polytrauma: The Nervous System & Physiological Systems
With ongoing wars in Iraq and Afghanistan, increasing numbers of civilians and military personnel are being exposed to explosive blasts. The injuries caused by these blasts are devastating, wreaking havoc on many parts of the body at once. The physicians and healthcare specialists treating the victims of these blasts must be aware of the complexity […]
ROAD TO HOPE documentary
VIDEO: The 2005 Road to Hope Tour traveled 7,000 miles from Washington, DC to San Francisco, CA visiting 23 schools and thousands of students. The tour featured HIV positive young people and advocates that joined together to educate and bring awareness to students around the country about HIV and AIDS. Hope’s Voice and joined forces with advocacy groups from around the country to put together this exciting tour.
Getting Beyond the Press Release Du Jour
The public relies heavily on media outlets to supply information on health and medicine. As purveyors of news that directly impacts people’s health decisions, journalists have an obligation to report stories that are balanced, accurate, and relevant.
One of the greatest challenges of health reporting is developing stories outside the established framework. Typically, journalists find […]
Is Screening and Early Detection Always Good?
Screening technologies for diseases such as prostate and breast cancer are constantly improving. The media eagerly reports stories about new tests and the public devours them because the underlying assumption is that screening can only be good. But this premise is flawed.
Screening results can be ambiguous; they do not necessarily lead to better […]
Medicine in the Media: The Challenge of Reporting Medical Research
In June 2005, the Seattle Times published “Suddenly Sick,” a five-part series by reporters Susan Kelleher and Duff Wilson illustrating the impact of disease definitions on medicine and the power of the pharmaceutical industry in shaping these definitions.
Disease is a relative concept, but medicine often defines it using strict quantitative parameters. For example, a body […]
Nursing Shortage: A Doctor’s Perspective
Barbara Ficarra, RN, Award-Winning Journalist, Executive Producer and Medical Show Host of Health in 30 and Nurses in Motion recently sat down with Fred Pescatore, M.D., NY Times-Best Selling Author and Practicing Family Physician in NY to continue the discussion on the nursing shortage.
The nursing shortage is a global complex issue, and there […]
Recent Trends in Nanodrug Delivery - Alan Minsk
Recent Trends in Nanodrug Delivery - Innovative Technologies and Commercial Viability…
One of the greatest impacts of nanomedicine is likely to take place in the context of drug delivery, which is poised to deliver to the market both evolutionary and revolutionary nanomedicines and devices. Early forecasts for nanomedicine commercialization are encouraging. However, there are challenges as […]
Bionanotechnology II: Drug Delivery - Ola Nerbrink
Recent Trends in Nanodrug Delivery - Innovative Technologies and Commercial ViabilityOne of the greatest impacts of nanomedicine is likely to take place in the context of drug delivery, which is poised to deliver to the market both evolutionary and revolutionary nanomedicines and devices.
Early forecasts for nanomedicine commercialization are encouraging.
However, there are challenges as well […]
The Future of Device Biologics
This timely presentation by AnneMarie Moseley, CEO, Aggregate Therapeutics, explores the impact of the converging medical device and biologic industries on the development of regenerative medicine products.
By assessing the influence of combination product regulations on both biologic and device products, it provides a necessary focus on the timeliness and cost of device-biologic development and […]
Sponsors
